Natera (NTRA) Cash from Operations Growth (1y) (2015 - 2026)
Natera (NTRA) Cash from Operations Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.85 Bn | 208.79 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 139.06 Bn | 134.71 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.19 Bn | 45.99 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.38 Bn | 37.57 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 38.07 Bn | 35.99 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 37.40 Bn | 36.30 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 28.63 Bn | 27.46 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.35 Bn | 28.30 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.74% |
| 10 | Labcorp Holdings | 25.85 Bn | 24.87 Bn | 1.01 Bn | 935.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.63% |
| Dec 31, 2025 | 39.71% |
| Sep 30, 2025 | 14.68% |
| Jun 30, 2025 | 841.70% |
| Mar 31, 2025 | 64.63% |
| Dec 31, 2024 | 191.81% |
| Sep 30, 2024 | 274.37% |
| Jun 30, 2024 | 105.08% |
| Mar 31, 2024 | 133.29% |
| Dec 31, 2023 | 28.99% |
| Sep 30, 2023 | 70.95% |
| Jun 30, 2023 | 29.14% |
| Mar 31, 2023 | 40.92% |
| Dec 31, 2022 | 17.83% |
| Sep 30, 2022 | -12.29% |
| Jun 30, 2022 | -57.09% |
| Mar 31, 2022 | -83.34% |
| Dec 31, 2021 | -34.70% |
| Sep 30, 2021 | -174.86% |
| Jun 30, 2021 | -72.19% |